Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v6.0)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-16

Query Trace: Leukemia and KIR2DL2[orginal query]

Certain Killer immunoglobulin like receptor (KIR)/ KIR HLA class I ligand genotypes influence NK antitumor activity in acute myelogenous leukemia but not in acute lymphoblastic leukemia. A case control leukemia association study Turkish journal of haematology : official journal of Turkish Society of Haematology 2019 Jul . Varbanova Viktoria Plamenova, Mihailova Snejina, Naumova Elissaveta, Mihaylova Anastasiya Petro Similar articles in PubMed
KIR repertory in patients with hematopoietic diseases and healthy family members. BMC hematology 2016 16 25. Sugioka Daniele Kazue, Gonçalves Carlos Eduardo Ibaldo, Bicalho Maria da Gra Similar articles in PubMed
KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia. Journal of immunology (Baltimore, Md. : 1950) 2015 May 194 (9): 4222-30. Marra John, Greene Justin, Hwang Jimmy, Du Juan, Damon Lloyd, Martin Tom, Venstrom Jeffrey Similar articles in PubMed
KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. Blood 2014 Oct 124 (17): 2744-7. Oevermann Lena, Michaelis Sebastian U, Mezger Markus, Lang Peter, Toporski Jacek, Bertaina Alice, Zecca Marco, Moretta Lorenzo, Locatelli Franco, Handgretinger Rupe Similar articles in PubMed
HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients. British journal of cancer 2014 Sep 111 (6): 1080-8. Zhao X-Y, Chang Y-J, Xu L-P, Zhang X-H, Liu K-Y, Li D, Huang X Similar articles in PubMed
Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma. Human immunology 2014 Jul 75 (7): 673-6. Vejbaesya Sasijit, Sae-Tam Pradermchai, Khuhapinant Archrob, Srinak Duangpo Similar articles in PubMed
Donor Haplotype B of NK KIR Receptor Reduces the Relapse Risk in HLA-Identical Sibling Hematopoietic Stem Cell Transplantation of AML Patients. Frontiers in immunology 2014 5 405. Impola Ulla, Turpeinen Hannu, Alakulppi Noora, Linjama Tiina, Volin Liisa, Niittyvuopio Riitta, Partanen Jukka, Koskela Sa Similar articles in PubMed
Homozygosity For Killer Immunoglobin-Like Receptor Haplotype A Predicts Complete Molecular Response To Treatment With Tyrosine Kinase Inhibitors In Chronic Myeloid Leukemia Patients. Experimental hematology 2013 Feb . La Nasa G, Caocci G, Littera R, Atzeni S, Vacca A, Mulas O, Langiu M, Greco M, Orrù S, Orrù N, Floris A, Carcassi C Similar articles in PubMed
Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission. Blood 2013 Feb 121 (7): 1157-64. Jennes Wim, Verheyden Sonja, Mertens Julie W, Camara Makhtar, Seydi Moussa, Dieye Tandakha N, Mboup Souleymane, Demanet Christian, Kestens L Similar articles in PubMed
KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib. Leukemia 2012 Feb 26 (2): 296-302. Marin D, Gabriel I H, Ahmad S, Foroni L, de Lavallade H, Clark R, O'Brien S, Sergeant R, Hedgley C, Milojkovic D, Khorashad J S, Bua M, Alsuliman A, Khoder A, Stringaris K, Cooper N, Davis J, Goldman J M, Apperley J F, Rezvani Similar articles in PubMed
The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population. Bone marrow transplantation 2010 Oct 45 (10): 1514-21. Wu G Q, Zhao Y M, Lai X Y, Luo Y, Tan Y M, Shi J M, Li L, Zheng W Y, Zhang J, Hu X R, Jin A Y, He J S, Xie W Z, Ye X J, Cai Z, Lin M F, Huang Similar articles in PubMed
Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease. Leukemia research 2010 Jan 34 (1): 55-8. Zhang Yan, Wang Bo, Ye Shihui, Liu Sheng, Liu Mengli, Shen Chunmei, Teng Yan, Qi J Similar articles in PubMed
Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia. Tissue antigens 2009 Jun 73 (6): 553-60. Middleton D, Diler A S, Meenagh A, Sleator C, Gourraud P Similar articles in PubMed
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood 2009 Jan 113 (3): 726-32. Cooley Sarah, Trachtenberg Elizabeth, Bergemann Tracy L, Saeteurn Koy, Klein John, Le Chap T, Marsh Steven G E, Guethlein Lisbeth A, Parham Peter, Miller Jeffrey S, Weisdorf Daniel Similar articles in PubMed
[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation]. Zhonghua yi xue za zhi 2007 Nov 87 (44): 3111-4. Dou Li-Ping, DA Wan-Ming, Zhao Dan-Dan, Wang Chang, Lu Xue-Chun, Kang Hui-Yuan, Yan Pei, Wang Fei-Fei, Zhu Hai-Yan, Li Hong-Hua, Gao Chun-Ji, Yu Similar articles in PubMed
Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. Journal of immunology (Baltimore, Md. : 1950) 2005 May 174 (10): 6540-5. Leung Wing, Iyengar Rekha, Triplett Brandon, Turner Victoria, Behm Frederick G, Holladay Marti S, Houston James, Handgretinger Rupe Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Jul 30, 2019
Page last updated:Oct 31, 2019
Content source:

TOP